First and second generations of COX-2 selective inhibitors

被引：1
作者：
de Leval, X
Julémont, F
Benoit, V
Frederich, M
Pirotte, B
Dogné, JM
机构：
[1] Univ Liege, Nat & Synth Drugs Res Ctr, Dept Med Chem, Med Chem Lab, B-4000 Liege, Belgium
[2] Univ Liege, Cellular & Moll Therapeut Ctr, B-4000 Liege, Belgium
来源：
MINI-REVIEWS IN MEDICINAL CHEMISTRY | 2004年 / 4卷 / 06期
关键词：
COX-2; inhibitors; selectivity; pre-clinical data;
D O I：
暂无
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
The identification and characterization of the inducible form of cyclooxygenases (COX-2) stimulated the investigations to develop efficient, non-steroidal anti-inflammatory drugs (NSAIDs) with reduced side effects (essentially gastro-intestinal toxicity) compared to classical NSAIDs. This review focuses on the chemical and pharmacological properties (pre-clinical data) of marketed COX-2 inhibitors.
引用
收藏
页码：597 / 601
页数：5
相关论文
共 39 条
[1]   Oral valdecoxib and injected parecoxib for acute postoperative pain: A quantitative systematic review [J].
Jodie Barden ;
Jayne E Edwards ;
Henry J McQuay ;
R Andrew Moore .
BMC Anesthesiology, 3 (1)
[2]  
Bennett A, 2000, Expert Opin Pharmacother, V1, P277, DOI 10.1517/14656566.1.2.277
[3]  
Bianchi M, 2002, INT J CLIN PRACT, P11
[4]   Effect of nimesulide on gastric acid secretion in the mouse stomach in vitro [J].
Borrelli, F ;
Tavares, IA .
LIFE SCIENCES, 2003, 72 (08) :885-896
[5]   COMPARISON OF THE SYSTEMIC INHIBITION OF THROMBOXANE SYNTHESIS, ANTIINFLAMMATORY ACTIVITY AND GASTROINTESTINAL TOXICITY OF NONSTEROIDAL ANTIINFLAMMATORY DRUGS IN THE RAT [J].
CARR, DP ;
HENN, R ;
GREEN, JR ;
BOTTCHER, I .
AGENTS AND ACTIONS, 1986, 19 (5-6) :374-375
[6]  
Chan CC, 1999, J PHARMACOL EXP THER, V290, P551
[7]   Vaidecoxib: A review [J].
Chavez, ML ;
DeKorte, CJ .
CLINICAL THERAPEUTICS, 2003, 25 (03) :817-851
[8]  
Crofford LJ, 1997, J RHEUMATOL, V24, P15
[9]  
de Leval X, 2000, CURR MED CHEM, V7, P1041
[10]   Characterization of rofecoxib as a cyclooxygenase-2 isoform inhibitor and demonstration of analgesia in the dental pain model [J].
Ehrich, EW ;
Dallob, A ;
De Lepeleire, I ;
Van Hecken, A ;
Riendeau, D ;
Yuan, WY ;
Porras, A ;
Wittreich, J ;
Seibold, JR ;
De Schepper, P ;
Mehlisch, DR ;
Gertz, BJ .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1999, 65 (03) :336-347
1234